| Identification | Back Directory | [Name]
ADRENORPHIN | [CAS]
88866-92-6 | [Synonyms]
ADRENORPHIN
Metorphacid
METORPHAMIDE
METORPHINAMIDE
ADRENORPHIN (FREE ACID)
METORPHAMIDE (FREE ACID)
Adrenorphin, ≥95% (HPLC)
Tyr-Gly-Gly-Phe-Arg-Arg-Val
8-L-Valineadrenorphin (human)
TYR-GLY-GLY-PHE-MET-ARG-ARG-VAL
H-TYR-GLY-GLY-PHE-MET-ARG-ARG-VAL-OH
Metorphamide (free acid) H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-OH | [Molecular Formula]
C44H68N14O10S | [MDL Number]
MFCD00076434 | [MOL File]
88866-92-6.mol | [Molecular Weight]
985.16 |
| Chemical Properties | Back Directory | [storage temp. ]
−20°C | [solubility ]
≥27.75 mg/mL in H2O with ultrasonic; ≥5.64 mg/mL in EtOH with ultrasonic; ≥98.5 mg/mL in DMSO | [form ]
solid |
| Hazard Information | Back Directory | [Biological Activity]
adrenorphin, also sometimes referred to as metorphamide, is an endogenous, c-terminally amidated, opioid octapeptide that is produced from proteolytic cleavage of proenkephalin a and is widely distributed throughout the mammalian brain(1). it was named based on the fact that it was originally detected in human phaeochromocytoma tumour derived from the adrenal medulla, and was subsequently found in normal human and bovine adrenal medulla as well. adrenorphin exhibits potent opioid activity, acting as a balanced μ- and κ-opioid receptor agonist while having no effects on δ-opioid receptors(2). it possesses analgesic and respiratory deppresive properties(3).figure 1 proteolytic cleavage of proenkephalin a | [References]
1. Matsuo H, Miyata A, Mizuno K (1983). "Novel C-terminally amidated opioid peptide in human phaeochromocytoma tumour". Nature 305 (5936): 721–3.2. Weber E, Esch FS, B?hlen P et al. (December 1983). "Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain". Proceedings of the National Academy of Sciences of the United States of America 80 (23): 7362–6.3. Xu SF, Lu WX, Zhou KR et al. (April 1985). "The analgesic and respiratory depressant actions of metorphamide in mice and rabbits". Neuropeptides 6 (2): 121–31. |
|
|